Concepedia

Amorphous Form Screening

Amorphous Form Screening is a preformulation screening method that identifies and characterizes the amorphous solid forms of a drug substance to evaluate their physicochemical stability, solubility, and potential for conversion to crystalline forms during pharmaceutical development.

19

Publications

757

Citations

100

Authors

37

Institutions

Publications per year

2017–2026

4

Parents

Publications

19

Specialized Solid Form Screening Techniques

Ann Newman · Organic Process Research & Development · 2012 · 128 citations

, , +13

Screening for differences in the amorphous state of indomethacin using multivariate visualization

Marja Savolainen, Andrea Heinz, Clare J. Strachan et al. · European Journal of Pharmaceutical Sciences · 2006 · 113 citations

, , +10

Development of a screening method for co-amorphous formulations of drugs and amino acids

Georgia Kasten, Holger Grohganz, Thomas Rades et al. · European Journal of Pharmaceutical Sciences · 2016 · 97 citations

, , +14

New perspectives of 19F MAS NMR in the characterization of amorphous forms of atorvastatin in dosage formulations

Martina Urbanová, Ivana Šeděnková, Hana Brusova · International Journal of Pharmaceutics · 2011 · 61 citations

, , +10

Co-amorphous Form of Curcumin–Folic Acid Dihydrate with Increased Dissolution Rate

Jenna Marie Skieneh, Indumathi Sathisaran, Sameer V. Dalvi et al. · Crystal Growth & Design · 2017 · 57 citations

, , +17

1–5 of 19

Authors

100

  1. TR
    Thomas Rades

    University of Copenhagen, Denmark

    2 publications · 210 citations

    2

    h-index

  2. DJ
    Daniel J. Korey

    1 publications · 23 citations

    1

    h-index

  3. IK
    In Kyu Lee

    Catholic University of Korea, South Korea

    1 publications · 34 citations

    1

    h-index

  4. AG
    Alejandro Gómez Pérez

    University of Antwerp, Belgium

    1 publications · 11 citations

    1

    h-index

  5. KS
    Kris Stoneburner

    Dow Chemical (United States), United States

    1 publications · 12 citations

    1

    h-index

1–5 of 100

Institutions

37

  1. Instytut Biotechnologii i Antybiotyków

    Warsaw, Poland

    2 h-index

    2 publications

    24 citations

  2. Durham University

    Durham, United Kingdom

    2 h-index

    5 publications

    74 citations

  3. Chiba University

    Chiba, Japan

    1 h-index

    5 publications

    210 citations

  4. The University of Osaka

    Osaka, Japan

    1 h-index

    6 publications

    180 citations

  5. Chungbuk National University

    Cheongju-si, South Korea

    1 h-index

    2 publications

    68 citations

  6. Kindeva Drug Delivery (United States)

    Saint Paul, United States

    1 h-index

    4 publications

    156 citations

  7. University of Patras

    Pátrai, Greece

    1 h-index

    1 publications

    11 citations

  8. Queen's University Belfast

    Belfast, United Kingdom

    1 h-index

    5 publications

    195 citations

1–8 of 37

Venues

  1. Crystal Growth & Design

    3 publications · 91 citations

    3

    h-index

  2. PubMed

    Repository · 2 publications · 35 citations

    2

    h-index

  3. European Journal of Pharmaceutical Sciences

    2 publications · 210 citations

    2

    h-index

  4. Applied Spectroscopy

    1 publications · 12 citations

    1

    h-index

  5. Chemical and Pharmaceutical Bulletin

    1 publications · 30 citations

    1

    h-index

1–5